Published in J Virol on March 01, 1994
Hepatitis B virus biology. Microbiol Mol Biol Rev (2000) 7.58
High-level hepatitis B virus replication in transgenic mice. J Virol (1995) 5.81
The enigmatic X gene of hepatitis B virus. J Virol (2004) 2.98
Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol (2005) 2.94
The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J (1995) 2.68
Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) (2010) 2.48
Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A (1994) 2.47
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol (2000) 2.23
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A (1995) 2.11
Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol (1998) 1.96
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol (1997) 1.95
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol (1995) 1.95
Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol (2001) 1.93
Hepatitis B virus-induced oncogenesis. World J Gastroenterol (2007) 1.82
Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1997) 1.79
Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol (2002) 1.78
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A (2009) 1.74
Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol (1996) 1.65
Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol (1996) 1.62
Hepatitis B virus X protein interferes with cellular DNA repair. J Virol (1998) 1.62
Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol (2001) 1.59
A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery. Nat Struct Mol Biol (2009) 1.58
Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol (1997) 1.58
Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol (1999) 1.57
Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol (2005) 1.56
Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J Virol (2003) 1.55
Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest (1996) 1.48
Viruses associated with human cancer. Biochim Biophys Acta (2007) 1.47
Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression. J Virol (2005) 1.47
Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities. J Virol (2003) 1.47
Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J Virol (1999) 1.46
The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci U S A (1997) 1.46
The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol (2005) 1.43
Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol (2001) 1.42
The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice. J Virol (1996) 1.40
The X protein of hepatitis B virus coactivates potent activation domains. Mol Cell Biol (1995) 1.36
Targeted DNA mutagenesis for the cure of chronic viral infections. J Virol (2012) 1.36
Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. J Virol (1996) 1.35
Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol (2001) 1.32
Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev (2012) 1.30
Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis (2007) 1.28
Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication. J Virol (2003) 1.28
Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol (2006) 1.27
X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. J Clin Invest (2001) 1.27
Hepatitis B virus pX targets TFIIB in transcription coactivation. Mol Cell Biol (1998) 1.26
Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol Ther (2013) 1.26
Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivity. J Virol (2005) 1.26
Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway. Mol Cell Biol (1997) 1.25
pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J (1996) 1.24
Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett (2010) 1.22
Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. J Virol (2001) 1.20
Transcriptional regulation of the TATA-binding protein by Ras cellular signaling. Mol Cell Biol (2000) 1.19
Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol (1998) 1.19
Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol (2008) 1.17
Hepatitis B virus X protein modulates apoptosis in primary rat hepatocytes by regulating both NF-kappaB and the mitochondrial permeability transition pore. J Virol (2009) 1.16
Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J Virol (2004) 1.15
Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner. PLoS Pathog (2010) 1.13
Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi. BMC Gastroenterol (2006) 1.12
Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol (2013) 1.10
Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha. Mol Cell Biol (1999) 1.09
Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice. J Virol (2000) 1.08
Duck hepatitis B virus expresses a regulatory HBx-like protein from a hidden open reading frame. J Virol (2001) 1.08
Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. J Virol (2008) 1.07
Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. J Virol (2005) 1.07
Hepatitis B virus replication is associated with an HBx-dependent mitochondrion-regulated increase in cytosolic calcium levels. J Virol (2007) 1.07
XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res (1996) 1.07
Apoptosis is induced by N-myc expression in hepatocytes, a frequent event in hepadnavirus oncogenesis, and is blocked by insulin-like growth factor II. J Virol (1996) 1.06
Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteins. J Virol (2002) 1.06
Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol (2014) 1.04
Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes. PLoS Pathog (2013) 1.04
Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol (1997) 1.03
Host cell-virus cross talk: phosphorylation of a hepatitis B virus envelope protein mediates intracellular signaling. J Virol (1998) 1.03
Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J Virol (2006) 1.01
Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model. Antimicrob Agents Chemother (2003) 1.00
Hepatitis B virus HBx protein localized to the nucleus restores HBx-deficient virus replication in HepG2 cells and in vivo in hydrodynamically-injected mice. Virology (2009) 1.00
Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids. J Virol (2013) 0.99
Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. J Clin Microbiol (2003) 0.99
Enrichment of a precore-minus mutant of duck hepatitis B virus in experimental mixed infections. J Virol (1999) 0.99
Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology (2007) 0.99
The hepatitis B virus X protein transactivates viral core gene expression in vivo. J Virol (1999) 0.98
Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex. J Virol (2002) 0.96
Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis. Proc Natl Acad Sci U S A (2002) 0.96
Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy. J Biol Chem (2008) 0.96
Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication. Hepatology (2011) 0.96
Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein. J Virol (2002) 0.95
Experimental models and therapeutic approaches for HBV. Semin Immunopathol (2012) 0.95
Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics. Antiviral Res (2015) 0.94
Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes. J Virol (2002) 0.94
Antiviral therapies and prospects for a cure of chronic hepatitis B. Cold Spring Harb Perspect Med (2015) 0.93
Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy. J Biol Chem (2010) 0.92
Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression. Hepatology (2009) 0.92
Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration. Cancer Res (2008) 0.92
Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter? World J Gastroenterol (2014) 0.91
pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants. Genes Dev (1998) 0.91
PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis. Cancer Res (2015) 0.91
Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein. J Virol (2003) 0.90
Metabolic labeling of woodchuck hepatitis B virus X protein in naturally infected hepatocytes reveals a bimodal half-life and association with the nuclear framework. J Virol (1998) 0.90
Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus. J Virol (2010) 0.89
Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell (1991) 13.69
The molecular biology of the hepatitis B viruses. Annu Rev Biochem (1987) 12.32
The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA. Nucleic Acids Res (1985) 12.11
HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (1991) 5.34
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci U S A (1987) 4.72
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature (1993) 3.88
HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science (1991) 3.78
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol (1993) 3.37
trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol (1988) 3.04
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol (1993) 2.84
Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature (1990) 2.69
Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol (1992) 2.54
Transcriptional trans-activating function of hepatitis B virus. J Virol (1987) 2.46
Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med (1985) 2.29
Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses. J Virol (1985) 2.24
Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol (1989) 2.21
Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus. J Virol (1984) 1.97
Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol (1992) 1.92
Molecular analysis of the function of direct repeats and a polypurine tract for plus-strand DNA priming in woodchuck hepatitis virus. J Virol (1989) 1.89
Identification of a signal necessary for initiation of reverse transcription of the hepadnavirus genome. J Virol (1991) 1.81
Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. Proc Natl Acad Sci U S A (1989) 1.61
The cloned genome of ground squirrel hepatitis virus is infectious in the animal. Proc Natl Acad Sci U S A (1984) 1.60
The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function. J Virol (1990) 1.55
The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res (1989) 1.45
Gene therapeutics. Nature (1991) 1.39
Activation of class I major histocompatibility complex gene expression by hepatitis B virus. J Virol (1990) 1.37
Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. J Virol (1992) 1.27
Expression of infectious woodchuck hepatitis virus in murine and avian fibroblasts. J Virol (1989) 1.25
In vitro recombinants of ground squirrel and woodchuck hepatitis viral DNAs produce infectious virus in squirrels. J Virol (1987) 1.20
Oncogenic potential of hepatitis B virus. Mol Biol Med (1989) 1.13
Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology (1987) 1.05
trans-activation by the hepatitis B virus X protein shows cell-type specificity. Virology (1989) 1.05
Effect of alpha interferon on the hepatitis C virus replicon. J Virol (2001) 6.18
The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell (1992) 4.72
Novel mechanism for reverse transcription in hepatitis B viruses. J Virol (1993) 4.47
Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science (1986) 4.12
Nucleotide sequence of an infectious molecularly cloned genome of ground squirrel hepatitis virus. J Virol (1984) 3.91
Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc Natl Acad Sci U S A (1996) 2.97
Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J (1997) 2.91
Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother (1997) 2.84
Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol (1994) 2.69
Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J Virol (1994) 2.29
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol (2001) 1.98
Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol (1997) 1.87
Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses. J Virol (1994) 1.87
Closed circular viral DNA and asymmetrical heterogeneous forms in livers from animals infected with ground squirrel hepatitis virus. J Virol (1983) 1.79
Replication of DHBV genomes with mutations at the sites of initiation of minus- and plus-strand DNA synthesis. Virology (1992) 1.77
Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J Virol (2000) 1.73
The cloned genome of ground squirrel hepatitis virus is infectious in the animal. Proc Natl Acad Sci U S A (1984) 1.60
Lamivudine therapy of WHV-infected woodchucks. Virology (1998) 1.52
Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses. Mol Cell Biol (1993) 1.38
Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. J Virol (1994) 1.37
In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology (1989) 1.34
Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology (1994) 1.29
In vitro recombinants of ground squirrel and woodchuck hepatitis viral DNAs produce infectious virus in squirrels. J Virol (1987) 1.20
Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine. Antimicrob Agents Chemother (1999) 1.16
Expression and characterization of hepadnavirus reverse transcriptases. Methods Enzymol (1996) 1.12
The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver. J Virol (1994) 1.08
Does a cdc2 kinase-like recognition motif on the core protein of hepadnaviruses regulate assembly and disintegration of capsids? J Virol (2001) 0.99
Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections. J Virol (2000) 0.99
A technique for liver biopsy performed in Pekin ducks using anesthesia with Telazol. Lab Anim Sci (1991) 0.95
[Immune reactions to posterior lamellar versus penetrating keratoplasty. A retrospective analysis]. Ophthalmologe (2012) 0.77
Beat-to-beat variation of heart rate in diabetic patients with autonomic neuropathy and in completely cardiac denervated patients following orthotopic heart transplantation. Int J Cardiol (1991) 0.75
[Experimental models for the study of hepadnaviruses and antiviral strategies]. Gastroenterol Clin Biol (1995) 0.75